Covered recipient · General Payments record
MICHELE HOLIFIELD PAGE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,874.29
- Reported across 26 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $730.70 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $228.65 | 3 |
| Phathom Pharmaceuticals, Inc. | $157.09 | 2 |
| Amgen Inc. | $132.73 | 3 |
| GENZYME CORPORATION | $123.81 | 1 |
| Novo Nordisk AS | $75.22 | 1 |
| DEXCOM, INC. | $13.20 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $104.45 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117580644 | CMS |
| Amgen Inc. | $13.74 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117580640 | CMS |
| Amgen Inc. | $14.54 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117580642 | CMS |
| AstraZeneca Pharmaceuticals LP | $90.21 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104765174 | CMS |
| AstraZeneca Pharmaceuticals LP | $125.01 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104586492 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.43 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104318868 | CMS |
| Dexcom, Inc. | $13.20 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153379574 | CMS |
| GENZYME CORPORATION | $123.81 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139660912 | CMS |
| Novo Nordisk Inc | $75.22 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100355304 | CMS |
| Phathom Pharmaceuticals, Inc. | $94.31 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151174713 | CMS |
| Phathom Pharmaceuticals, Inc. | $62.78 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151174715 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.